{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:42:50Z","timestamp":1773016970345,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1591,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL036444, CA18029, AI33484, and CA15704"],"award-info":[{"award-number":["HL036444, CA18029, AI33484, and CA15704"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.bbmt.2010.06.003","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T06:52:37Z","timestamp":1276239157000},"page":"1700-1706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Tumor Necrosis Factor Polymorphism Affects Transplantation Outcome in Patients with Myelodysplastic Syndrome but Not in Those with Chronic Myelogenous Leukemia, Independent of the Presence of HLA-DR15"],"prefix":"10.1016","volume":"16","author":[{"given":"Laura F.","family":"Newell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Gooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek L.","family":"Stirewalt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effie W.","family":"Petersdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Joachim","family":"Deeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.06.003_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0168-9525(90)90042-5","article-title":"The major histocompatibility complex and human evolution (review)","volume":"6","author":"Klein","year":"1990","journal-title":"Trends Genet"},{"key":"10.1016\/j.bbmt.2010.06.003_bib2","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1182\/blood-2005-05-1958","article-title":"Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence","volume":"107","author":"Battiwalla","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbmt.2006.12.442","article-title":"HLA-DR15, reduced relapse rate and improved survival after HLA identical sibling hemopoietic stem cell transplantation","volume":"13","author":"Davidson","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.003_bib4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.bbmt.2006.07.001","article-title":"Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen\u2013identical sibling hematopoietic stem cell transplantation","volume":"12","author":"Stern","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.003_bib5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor \u03b1 precede major complications of bone marrow transplantation","volume":"75","author":"Holler","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.bmt.1704929","article-title":"Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept","volume":"35","author":"Wolff","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.003_bib7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood.V100.5.1570.h81702001570_1570_1574","article-title":"HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome","volume":"100","author":"Saunthararajah","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exphem.2006.09.002","article-title":"Roles of DRB1\u22171501 and DRB1\u22171502 in the pathogenesis of aplastic anemia","volume":"35","author":"Sugimori","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2010.06.003_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hon.907","article-title":"Experimental and clinical characteristics in myelodysplastic syndrome patients with or without the HLA-DR I 5 allele","volume":"28","author":"Xiao","year":"2010","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.bbmt.2010.06.003_bib10","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1182\/blood.V98.13.3513","article-title":"Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH\/aplastic anemia syndrome","volume":"98","author":"Maciejewski","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-3083.1996.d01-65.x","article-title":"Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles: relevance for inflammatory bowel disease","volume":"43","author":"Bouma","year":"1996","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.bbmt.2010.06.003_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(97)00052-7","article-title":"The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription","volume":"34","author":"Kroeger","year":"1997","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bbmt.2010.06.003_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2249.2007.03564.x","article-title":"Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians (review)","volume":"151","author":"Sharma","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2010.06.003_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1744-313X.2007.00715.x","article-title":"Genetic susceptibility to SLE is associated with TNF-alpha gene polymorphism -863, but not -308 and -238, in Thai population","volume":"34","author":"Hirankarn","year":"2007","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.bbmt.2010.06.003_bib15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2006.10.114","article-title":"Allele-specific chromatin remodeling of the tumor necrosis factor-alpha promoter","volume":"351","author":"Skoog","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bbmt.2010.06.003_bib16","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1128\/MCB.20.24.9113-9119.2000","article-title":"Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region","volume":"20","author":"Udalova","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bbmt.2010.06.003_bib17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2002-02-0527","article-title":"Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome","volume":"100","author":"Deeg","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2002-08-2619","article-title":"HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen","volume":"102","author":"Radich","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/bbmt.2001.v7.pm11302550","article-title":"Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation","volume":"7","author":"Anderson","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.003_bib20","series-title":"Chronic Graft Versus Host Disease: Interdisciplinary Management","first-page":"56","article-title":"Clinical manifestations and natural history","author":"Flowers","year":"2009"},{"key":"10.1016\/j.bbmt.2010.06.003_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib22","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.bbmt.2007.06.007","article-title":"Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation","volume":"13","author":"Mielcarek","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.003_bib23","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1182\/blood.V92.10.3515","article-title":"Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient","volume":"92","author":"Petersdorf","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib24","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa022060","article-title":"Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation","volume":"349","author":"Lin","year":"2003","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.bbmt.2010.06.003_bib25","series-title":"Biostatistics: A Methodology for the Health Sciences","author":"Fisher","year":"1993"},{"key":"10.1016\/j.bbmt.2010.06.003_bib26","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood.V92.10.3943","article-title":"Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants","volume":"92","author":"Middleton","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib27","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/sj.bmt.1702724","article-title":"Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation","volume":"26","author":"Takahashi","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.003_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1744-313X.2006.00630.x","article-title":"Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation","volume":"33","author":"Bertinetto","year":"2006","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.bbmt.2010.06.003_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.0001-2815.2004.00218.x","article-title":"Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation","volume":"63","author":"Shaw","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2010.06.003_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00933.x","article-title":"A role for tumor necrosis factor-a, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome","volume":"103","author":"Gersuk","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2010.06.003_bib31","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2002-11-3567","article-title":"Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells","volume":"102","author":"Bornhauser","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib32","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V98.13.3569","article-title":"Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of the 4 randomized studies","volume":"98","author":"Soci\u00e9","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib33","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood.V89.8.3055","article-title":"Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation","volume":"89","author":"Slattery","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.003_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbmt.2005.12.036","article-title":"Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan\/cyclophosphamide regimen","volume":"12","author":"Deeg","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.003_bib35","series-title":"Thomas' Hematopoietic Cell Transplantation","first-page":"1164","article-title":"Nonmyeloablative therapy and hematopoietic cell transplantation for hematologic disorders","author":"Sandmaier","year":"2004"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110002429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110002429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:37:59Z","timestamp":1761057479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110002429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1083879110002429"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.06.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Necrosis Factor Polymorphism Affects Transplantation Outcome in Patients with Myelodysplastic Syndrome but Not in Those with Chronic Myelogenous Leukemia, Independent of the Presence of HLA-DR15","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}